Startup Funding Tracker
Home›Companies›Healthcare›Cognixion

Cognixion Corp

Cognixion builds wearable brain interfaces that help people with complex disabilities communicate and control connected technology.

ActiveHealthcare · Medical devices
Updated Nov 8, 2026·Latest SEC filing Oct 21, 2026·Suggest an edit

About Cognixion

Cognixion makes wearable communication systems for people whose disabilities limit speech and movement. Its headset reads brain activity without surgery and lets users choose digital options without their hands or voices. Cognixion ONE places these choices on a display in the user's view. Its language software learns each person's communication style, while Alexa connectivity can control smart devices and provide information.

Based in Santa Barbara, Cognixion is led by founder and CEO Andreas Forsland. Chris Ullrich is chief technology officer and principal investigator of the CHOICE Study. Cognixion ONE Axon received Breakthrough Device Designation from the U.S. Food and Drug Administration. The company also operates Cognixion Inc., its Canadian subsidiary.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 7, 2025Oct 21, 2026$900,000of $10.0M target2$450KOptions, SAFE investmentRule 506(b)Form D ↗
Jan 30, 2026Feb 3, 2026$4,050,000fully sold4$1.0MDebtRule 506(b)Form D ↗
May 31, 2024Jun 5, 2024amended Jan 10, 2025$6,038,517fully sold19$317KEquity, Securities on exerciseRule 506(b)Form D/A ↗2 earlier filings
Oct 2, 2023Oct 4, 2023amended Dec 20, 2023$1,939,097of $5.0M target13$149KDebtRule 506(b)Form D/A ↗3 earlier filings
Nov 12, 2021Nov 15, 2021$12,989,289fully sold22$590KEquity, Options, Securities on exercise, Series Seed-2A Preferred and Series Seed-2B PreferredRule 506(b)Form D ↗
Mar 22, 2021Apr 15, 2021amended Jun 14, 2021$885,300of $1.0M target3$295KOptions, SAFE instrumentRule 506(b)Form D/A ↗1 earlier filing
Nov 19, 2019Nov 20, 2019amended Oct 1, 2020$4,120,139of $4.1M target3$1.3MEquity, Options, Series Seed PreferredRule 506(b)Form D/A ↗6 earlier filings
Jul 30, 2018Aug 3, 2018amended Jul 12, 2019$1,766,000fully sold6$294KDebt, Unsecured Promissory NotesRule 506(b)Form D/A ↗1 earlier filing
Total, eight offerings$32,688,342

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Rounds announced by Cognixion

What the company said publicly about its funding. Announced amounts can differ from Form D figures: an announcement can combine several closings, and some money is raised without a Form D.

AnnouncedRoundAmountInvestorsSource
Nov 16, 2021Seed$12 millionPrime Movers Lab (lead), Northwell Health, Amazon Alexa Fund and Volta CircleCognixion announcement ↗

Why Investors Backed Cognixion

Cognixion develops wearable systems that turn brain activity into computer commands without surgery. Axon-R gives clinical teams tools to study attention, cognition and assistive technology. Its interface can use brain signals alone or combine them with eye tracking. Axon-R is for research only and lacks clearance from U.S. and Canadian regulators.

The problem it targets

People with ALS can lose speech and movement as the disease advances, making daily communication harder. Assistive tools then become an important link to family and caregivers. Reduced eye-gaze ability can affect some patients as their disease progresses. Travel to research sites can also burden participants, so at-home studies can capture use in familiar surroundings.

What the product does

Axon-R pairs electroencephalography, which records brain signals without implants, with an augmented-reality display and researcher software. A planned Pupil Labs integration would synchronize eye movements and neural signals through one developer interface. The partners intended this setup for rapid study prototypes and applications that respond to either signal. Cognixion ONE can also make selections from brain signals alone.

Progress so far

The NIH-backed CHOICE Study plans to enroll 30 adults with ALS across the United States. Participants will compare three communication options at home for about 12 weeks. Researchers will track which option each participant chooses voluntarily. The first budget year has $1,258,551 in federal funding. Cognixion was named a 2025 Tech for Global Good Laureate and MedTech World's 2026 wearable and implantable technology of the year.

Who backs it

Prime Movers Lab led Cognixion's 2021 seed financing, joined by Northwell Health, Amazon Alexa Fund and Volta Circle. Prime Movers Lab also helped with hiring, marketing, government relations and prospective customers. Northwell said its health-care expertise could support Cognixion's expansion into provider markets. The National Institute on Deafness and Other Communication Disorders funds the CHOICE Study.

How the market is moving

Pupil Labs CEO Moritz Kassner reported growing demand from research partners for combined eye-tracking and brain-sensing systems. Pupil Labs serves more than 10,000 professional users. Researchers have published nearly 1,000 papers using its tools. Those figures reflect Pupil Labs' reach, not the size of the broader brain-interface market.

We wrote this summary from public statements by Cognixion and its investors. It is not investment advice.

Cognixion in the News

Leadership Team

Executive officers and directors listed on Cognixion's Form D filed Oct 21, 2026.

Andreas Forsland
Andreas Forsland
Founder and CEO, director
LinkedIn ↗
TG
TW
AK
Amy Kruse
Prime Movers Lab and director
LinkedIn ↗
Also a director at Gilgamesh Pharma, Morphoceuticals and Motif Neurotech.
JK

Earlier filings also listed Thomas Washing (director, last listed Jan 2025), Diana Pereira (chief financial officer, last listed Jun 2021), Leonard Zerman (director, last listed Oct 2020) and Thomas Ladd (director, last listed Jul 2019).

Sources

  1. SECCognixion Corp Form D/A, filed Dec 30, 2024
  2. SECCognixion Corp Form D, filed Jun 5, 2024
  3. SECCognixion Corp Form D/A, filed Nov 14, 2023
  4. SECCognixion Corp Form D/A, filed Oct 23, 2023
  5. SECCognixion Corp Form D, filed Oct 4, 2023
  6. SECCognixion Corp Form D, filed Apr 15, 2021
  7. SECCognixion Corp Form D/A, filed Aug 12, 2020
  8. SECCognixion Corp Form D/A, filed May 11, 2020
  9. SECCognixion Corp Form D/A, filed Jan 29, 2020
  10. SECCognixion Corp Form D/A, filed Dec 23, 2019
  11. SECCognixion Corp Form D/A, filed Dec 18, 2019
  12. SECCognixion Corp Form D, filed Nov 20, 2019
  13. SECCognixion Corp filing history
  14. CompanyCognixion News
  15. CompanyCHOICE Study announcement
  16. CompanyPupil Labs partnership announcement
  17. CompanyChris Ullrich appointment
  18. CompanyCognixion privacy policy
  19. CompanyCognixion financial conflict policy
  20. PressACCESS Newswire partnership release